These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Chromium(III) ion and thyroxine cooperate to stabilize the transthyretin tetramer and suppress in vitro amyloid fibril formation. Sato T, Ando Y, Susuki S, Mikami F, Ikemizu S, Nakamura M, Suhr O, Anraku M, Kai T, Suico MA, Shuto T, Mizuguchi M, Yamagata Y, Kai H. FEBS Lett; 2006 Jan 23; 580(2):491-6. PubMed ID: 16386248 [Abstract] [Full Text] [Related]
6. Kinetic stabilization of an oligomeric protein by a single ligand binding event. Wiseman RL, Johnson SM, Kelker MS, Foss T, Wilson IA, Kelly JW. J Am Chem Soc; 2005 Apr 20; 127(15):5540-51. PubMed ID: 15826192 [Abstract] [Full Text] [Related]
13. Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: a focus on the transthyretin amyloidoses. Johnson SM, Wiseman RL, Sekijima Y, Green NS, Adamski-Werner SL, Kelly JW. Acc Chem Res; 2005 Dec 20; 38(12):911-21. PubMed ID: 16359163 [Abstract] [Full Text] [Related]
14. The binding of 2,4-dinitrophenol to wild-type and amyloidogenic transthyretin. Morais-de-Sá E, Neto-Silva RM, Pereira PJ, Saraiva MJ, Damas AM. Acta Crystallogr D Biol Crystallogr; 2006 May 20; 62(Pt 5):512-9. PubMed ID: 16627944 [Abstract] [Full Text] [Related]
15. Kinetic stabilization of the native state by protein engineering: implications for inhibition of transthyretin amyloidogenesis. Foss TR, Kelker MS, Wiseman RL, Wilson IA, Kelly JW. J Mol Biol; 2005 Apr 08; 347(4):841-54. PubMed ID: 15769474 [Abstract] [Full Text] [Related]
16. D18G transthyretin is monomeric, aggregation prone, and not detectable in plasma and cerebrospinal fluid: a prescription for central nervous system amyloidosis? Hammarström P, Sekijima Y, White JT, Wiseman RL, Lim A, Costello CE, Altland K, Garzuly F, Budka H, Kelly JW. Biochemistry; 2003 Jun 10; 42(22):6656-63. PubMed ID: 12779320 [Abstract] [Full Text] [Related]